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Objective: A premorbid IQ deﬁcit supports a developmental dimension to schizophrenia and its cognitive
aspects that are crucial to functional outcome. Better characterisation of the association between premorbid
IQ and the disorder may provide further insight into its origin and etiology. We aimed to quantify premorbid
cognitive function in schizophrenia through systematic review andmeta-analysis of longitudinal, population-
based studies, and to characterize the risk of schizophrenia across the entire range of premorbid IQ.
Method: Electronic and manual searches identiﬁed general population-based cohort or nested case–control
studies that measured intelligence before onset of schizophrenic psychosis using standard psychometric
tests, and that deﬁned cases using contemporaneous ICD or DSM. Meta-analyses explored dose–response
relationships between premorbid cognitive deﬁcit (using full-scale, verbal and performance IQ) and risk of
schizophrenia. Meta-regression analyses explored relationships with age of illness onset, change in premorbid
intelligence over time and gender differences.
Results: Meta-analysis of 4396 cases and over 745000 controls from 12 independent studies conﬁrmed
signiﬁcant decrements in premorbid IQ (effect size−0.43) among future cases. Risk of schizophrenia operated
as a consistent dose–response effect, increasing by 3.7% for every point decrease in IQ (pb0.0001). Verbal and
nonverbalmeasureswere equally affected. Greater premorbid IQ decrementwas associatedwith earlier illness
onset (pb0.0001). There was no evidence of a progressively increasing deﬁcit during the premorbid period
toward illness onset.
Conclusions: Strong associations between premorbid IQ and risk for schizophrenia, and age of illness onset
argue for a widespread neurodevelopmental contribution to schizophrenia that operates across the entire
range of intellectual ability. This also suggests higher IQ may be protective in schizophrenia, perhaps by
increasing active cognitive reserve.
© 2011 Elsevier B.V. Open access under CC BY license. 1. Introduction
Identiﬁcation of premorbid IQ deﬁcits in people who will later
develop schizophrenia is a key piece of evidence underpinning a
developmental aspect to the disorder. This has been summarized as a
neurodevelopmental theory (Murray and Lewis, 1987; Weinberger,
1987), for which there is empirical evidence (Jones et al., 1994;
Weinberger, 1995). However, fundamental questions have yet to be
settled. These include the absolute magnitude of premorbid IQ deﬁcit,
whether this is due to a decrement in the majority of future cases
(a left-shift of this population), or whether it is due to aminority effect
driven by a sub-group with conspicuously low IQ. Many studies usingardized Mean Difference.
try, University of Cambridge,
CB2 2QQ, UK. Tel.: +44 1223
andaker).
 license. several designs have generally assessed mean differences between
cases (or future cases) and controls (Aylward et al., 1984; Woodberry
et al., 2008), rather than addressing these underlying concerns. These
concerns are important because their solutions shed light on causal
models of the entire syndrome of schizophrenia, and the cognitive
dysfunction that is an important determinant of functional outcome.
Assessing premorbid intelligence is problematic. Previous reviews
on this topic were based on studies with a number of methodological
limitationswhichmight affect both validity and generalizability of their
results (Aylward et al., 1984; Woodberry et al., 2008). Case control
studies are liable to selection bias, which can lead to large variations in
effect size through unrepresentative comparison groups (Lubin et al.,
1962; Brewer et al., 2005; Lencz et al., 2006). On the other hand, genetic
high risk studies or studies of childhood psychiatric clinic attendees are
often small, andmay reﬂect atypical groupsof patients;most individuals
who develop schizophrenia have neither a positive family history
(Gottesman and Sheilds, 1982) nor a history of psychiatric treatment in
childhood. Therefore, themost accurate estimateofpremorbid cognitive
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longitudinal population-based studies, which are more representative
and less prone to selection bias than other designs.
We report a systematic review and meta-analysis of population-
based studies of premorbid intelligence in schizophrenia. We aimed
not only to provide an accurate estimate of the magnitude of
premorbid IQ deﬁcit, but also to characterize the variation in risk
across the entire range of premorbid intellectual ability. We proposed
that neurodevelopmental impairment in patients with schizophrenia
operates across the normal distribution of IQ (Jones et al., 1994), and
that IQ decrement would reﬂect this. We predicted that there would
be a dose–response relationship between risk of schizophrenia
and premorbid intelligence operating across the full range of IQ (as
opposed to a neurodevelopmentally-impaired subgroup of patients).
We proposed that the degree of premorbid IQ deﬁcit may reﬂect the
degree of developmental impairment at that age. Thus, we predicted
that (a) the IQ deﬁcit would be greater in individuals who show
an earlier illness onset, and (b) the IQ deﬁcit would increase with
proximity between the measure of IQ and illness onset, as betrayed
by an association between age and effect size once confounding by
the measurement within the prodromal state was excluded. If the
second scenario were true this would be consistent with a progressive
IQ deﬁcit.
2. Methods
2.1. Search strategy
Medline-PubMed, PsycINFO and Embase databases were searched
to identify all studies of intelligence and schizophrenia published in
English language from January 1984 (the year of the ﬁrst review on
this topic) (Aylward et al., 1984), until February 2011. Search terms
included both MeSH terms and text words, and were: ([Premorbid
OR School performance OR Childhood precursor OR Childhood
antecedent] OR [IQ OR Intelligence quotient OR Intelligence tests OR
IntelligenceOR Cognitive ORNeuropsychological]) AND (Schizophrenia
OR Psychosis). We also hand searched reference lists of included
studies and related conference proceedings, and contacted prominent
researchers in this ﬁeld for unpublished work.
2.2. Study selection
Included studies (i) were general population-based cohort or
nested case–control designs, (ii) measured intelligence by standard
psychometric tests in childhood or before onset/diagnosis of illness,
(iii) established outcome according to contemporaneous ICD or
DSM, and (iv) used population based registers or cohorts to identify
cases. Diagnostic outcomes were schizophrenia, schizophreniform,
schizoaffective, schizotypal disorder and psychotic disorders. Studies
that estimated premorbid IQ rather than directly measuring it, or that
used school performance, etc. as proxieswere excluded. In case of more
than one published reports from the same population we included the
studywith longer followup and larger sample; e.g. Zammit et al. (2004)
instead of David et al. (1997) from Sweden; Urfer-Parnas et al. (2010)
instead of Mortensen et al. (2005) from Denmark.
2.3. Data extraction
GMK examined all titles and abstracts, and obtained full texts of
potentially relevant papers. GMK, JHB and PBJ read the papers and
applied inclusion criteria. Data were extracted independently, and
disagreements were resolved by consensus. For each report, study
setting and sampling strategy, age and method of IQ measurement,
follow up, attrition and method of case ascertainment were extracted.
Measures of premorbid full-scale, verbal and performance IQ in case
and control groups were identiﬁed from each study. Where data werereported in a format that did not allow meta-analysis, an appropriate
format was requested from the authors. When studies reported more
than onemeasure, or repeat assessments of IQ, themost comprehensive
measure was used (see Supplementary Online Methods).
2.4. Data synthesis
Differences in premorbid IQ between cases and controls were
expressed as the standardized mean difference (SMD, Cohen's d),
which is appropriate when studies assess the same variable but
measure it in a variety of ways (Egger et al., 2001). Meta-analyses
combined the SMD for premorbid full-scale, verbal and performance IQ.
Heterogeneity between study samples was assessed using Cochrane's
heterogeneity statistic Q; random effect methods were used to allow
for heterogeneity between studies (Egger et al., 2001). The I2 statistic
was calculated to express the fraction of variation between studies that
was due to heterogeneity (Higgins et al., 2003).
To estimate the risk associated with different levels of premorbid
IQ, 5 available study samples were divided into 6 groups (IQb−2SD,
−2 to−1SD,−1 SD to 0, 0 to 1SD, 1 to 2SD and N2SD); the 0 to 1 SD
group was used as reference. Three conscript studies reported data in
9 IQ groups (Gunnell et al., 2002; Zammit et al., 2004; Tiihonen et al.,
2005); we merged the groups to create 6 IQ groups reﬂecting similar
proportions of the population as in the above six-group classiﬁcation.
Average IQ for each of these 6 groups was then calculated.
The dose–response relationship between IQ and risk of schizophre-
nia was assessed in two ways. First, we plotted the dose–response
relationship in the 6 groups and combined them using multivariate
random-effectsmeta-analysis (White, 2008). Second, logistic regression
analysis was carried out to test for linearity. We ﬁtted a quadratic
model to each study, using group-speciﬁc mean IQ and its square as
explanatory variables, and combined the quadratic terms in a random-
effects meta-analysis: a mean signiﬁcantly different from zero indicates
overall non-linearity, while signiﬁcant heterogeneity indicates that
non-linearity occurs in at least some studies but differs between studies.
Longitudinal data with repeat measures of IQ on the same sample
were available from only three studies (Jones et al., 1994; Crow et al.,
1995; Cannon et al., 2002). In order to assess any change in IQ during
the premorbid period, we plotted the Z scores at different age points
to examine any change in IQ deﬁcit over time. In addition, we
separately meta-analyzed studies where IQ testing occurred ‘early’
(between age 7 and 12 years) versus ‘late’ (16–19 years), and tested
the difference between these effect sizes (Altman and Bland, 2003).
Meta-regression was also used to assess whether the magnitude of
deﬁcit in premorbid IQ correlated with the age of IQ testing.
Meta-regression was used to examine the association between
degree of IQ deﬁcit and age of onset of schizophrenia. To test whether
premorbid IQ decrement differed between men and women we
carried out meta-regression of SMD on proportion of men among
cases, adjusting for the age of IQ testing. Publication bias was assessed
using funnel plots and Egger's test (Egger et al., 1997). Data were
analyzed using ComprehensiveMeta-Analysis Version 2.0 (Biostat Inc,
Englewood, NJ, USA) and STATA 10 (StataCorp LP, Texas, USA).
3. Results
Electronic search identiﬁed 471 studies. On the basis of title and
abstracts 25 (5.3%) potentially eligible studies were identiﬁed, of
which 13 met inclusion criteria. One additional study was obtained
from correspondence with authors. In total 14 studies were included
in the review (Table 1).
3.1. Premorbid IQ in schizophrenia
A measure of premorbid full-scale IQ was available from 12
studies, which included 4396 cases and 745720 controls (Jones et al.,
Table 1
Studies included in the systematic review of premorbid intelligence and Schizophrenia.
Study Design and setting Diagnostic criteria and
outcome
Case
(n)
Control
(n)
% of cases
male
Age at
follow up
(years)
IQ test age
(years)
Mean age of
onset, years
(SD)
IQ tests Case identiﬁcation Adjustment for confounding
Jones et al.
(1994)
PCa—British 1946
birth cohort
DSM III R
schizophrenia
24 4133 66.6 43 8, 11, 15 23.4 (2.7) 1st principal componentb Questionnaire, interview,
hospital discharge register,
present state examination
Age, social class
Crow et al.
(1995)
PC—British 1958
birth cohort
PSE CATEGOc
schizophrenia
29 1446 51.7 28 7, 11, 16 – General ability test Hospital discharge register Social class
Cannon et al.
(2000)
PC—NCPP:
Philadelphia
cohort, USAd
DSM IV Schizophrenia
or schizoaffective
57 5829 72 19–36 4, 7 – Wechsler intelligence scale for
children (WISC)
Hospital discharge register Socio-demographic, obstetric,
behavioral factors
Walker et al.
(2002)
RCe—Scottish
mental ability
survey 1932
ICD10: F20–29
Schizophrenia and
related conditions
32 3764 65.5 66 11 36.5 (16.6)f Moray house test Hospital discharge register Age
Cannon et al.
(2002)
PC—Dunedin birth
cohort, New
Zealand
DSM IV
Schizophreniform
33 598 – 32 3, 5, 7, 9,
11
– Revised Wechsler intelligence
scale for children (WISC-R)
Diagnostic interview
schedule (DIS)
Socioeconomic, obstetric and
maternal factors
Gunnell
et al. (2002)
RC—Swedish
conscript cohort
ICD 10 schizophrenia 60 109491 100 18–25 18 20.8 (1.5)f Synonym and visuospatial test National Inpatient Discharge
Register
Age, obstetric and maternal
factors, parental education
Caspi et al.
(2003)
NCCg—Israeli
conscript cohort
DSM IV schizophrenia 44 44 75 19–31 16–17 22.5 (3.5)f Modiﬁed Raven's progressive
matrices, Otis type verbal IQ test
Structured Clinical Interview
for DSM (SCID)
Sex, country of origin, age,
education
Niendam et al.
(2003)h
NCC—NCPP:
Philadelphia
cohort, USA
DSM IV schizophrenia
or schizoaffective
32 201 34 19–36 7 – Vocabulary and block design Hospital discharge register Age, socio-economic status
Zammit et al.
(2004)
RC—Swedish
conscript cohort
ICD 8 and ICD 9
Schizophrenia
362 49161 100 45–47 18 28.2 (5.9)f Visuospatial test National Inpatient discharge
register
–
Reichenberg
et al. (2005)
RC—Israeli
conscript cohort
ICD 10 Schizophrenia 1856 549466 76 24–34 16–17 23.8 (3.7)f Verbal and non-verbal analogies National Inpatient discharge
register
Sex, socioeconomic status
Tiihonen et al.
(2005)i
RC—Finnish
conscript cohort
ICD 8 and ICD 9
schizophrenia
607 189027 100 27 19.9 – Verbal, arithmetic and
visuospatial reasoning tests
National inpatient discharge
register
Age, over-all test performance
Seidman et al.
(2006)
NCC—NCPP: New
England cohort, USA
DSM IV schizophrenia 31 61 79.4 28 7 – Wechsler intelligence scale for
children (WISC)
DIS, SCID, hospital discharge
register
Sex, ethnicity, socioeconomic
status
Osler et al.
(2007)
PC—Danish
longitudinal study
ICD 10 schizophrenia 87 6790 100 19–49 12 35.2 (9.6)f Härnquist test National inpatient discharge
register
Birth weight, social class,
education, marital status,
employment
Urfer-Parnas
et al. (2010)
NCC—Danish
conscript cohort
ICD 8 to ICD 10
schizophrenia
1779 20531 100 43–54 19.5 30.4 (7.8)f Børge Priens Prøve (letter matrices,
verbal analogies, number series,
geometric ﬁgures)
National inpatient discharge
register
–
a PC—Prospective cohort study.
b 1st principal component derived from all tests used at each age which included tests for verbal, nonverbal and mathematical skills.
c Present state examination and CATEGO.
d National Collaborative Perinatal Project (NCPP)—USA.
e RC—Retrospective cohort study.
f Age at the time of ﬁrst hospital admission for schizophrenia.
g NCC—Nested case–control study.
h Study sample is a sub-set of T Cannon et al. (2000) used in the meta-analysis of premorbid verbal and performance IQ.
i Study used only in the dose–response analysis as data was not available in appropriate format to use in other analyses.
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223G.M. Khandaker et al. / Schizophrenia Research 132 (2011) 220–2271994; Crow et al., 1995; Cannon et al., 2000; Gunnell et al., 2002;
Walker et al., 2002; Caspi et al., 2003; Zammit et al., 2004;
Reichenberg et al., 2005; Seidman et al., 2006; Osler et al., 2007;
Urfer-Parnas et al., 2010). Standardized Mean Difference (SMD) in
premorbid full-scale IQ between cases and controls was −0.43 (95%
conﬁdence interval (CI) −0.53 to −0.34), pb0.0001; see Fig. 1. This
equates to a mean premorbid IQ of 93.6 in people who develop
schizophrenia, compared with a population mean of 100 (SD 15).
There was however, signiﬁcant heterogeneity in effect size between
studies, (pb0.001; I2=77%).
3.2. Verbal and performance IQ
Both verbal and performance IQ were signiﬁcantly lower in
individuals who later developed schizophrenia. Ten studies reported
valid measures of both premorbid verbal and performance IQ (Jones
et al., 1994; Crow et al., 1995; Cannon et al., 2002; Gunnell et al., 2002;
Caspi et al., 2003; Niendam et al., 2003; Zammit et al., 2004;
Reichenberg et al., 2005; Seidman et al., 2006; Osler et al., 2007).
Meta-analysis of verbal IQ included 2349 cases and 669096 controls
and showed a SMD of −0.43 (95% CI −0.52 to −0.33), pb0.0001.
Meta-analysis of performance IQ included 2477 cases and 691965
controls and showed a SMD of −0.43 (95% CI −0.55 to −0.31),
pb0.0001. There was no signiﬁcant difference between deﬁcits in
premorbid verbal and performance IQ (p=0.46). Heterogeneity of
effects among studies of verbal IQ was marginally non-signiﬁcant
(p=0.08; I2=41%), but signiﬁcant heterogeneity was observed
among studies of performance IQ (p=0.001; I2=65%).
3.3. Dose response relationship between IQ and risk of schizophrenia
Data from ﬁve cohorts were available for this analysis (Jones
et al., 1994; Gunnell et al., 2002; Zammit et al., 2004; Reichenberg
et al., 2005; Tiihonen et al., 2005). Compared with the group withFig. 1. Forest plot of premorbid full-scale IQ among a total of 4396 cases and 745720 controls
study. The diamonds indicate pooled SMD from two groups of studies deﬁned by age of IQ tes
indicates the point of no difference in premorbid IQ between schizophrenia cases and contIQ between the population mean and one SD above the mean (i.e. IQ
100 to 115), the risk of developing schizophrenia was more than
doubled among individuals with IQ between 70 and 85 (Odds
ratio (OR) 2.36, 95% CI 1.59 to 3.49), while risk was nearly ﬁve-
fold for those with IQ below 70 (OR 4.78, 95% CI 3.19 to 7.13);
see Fig. 2. High premorbid intelligence reduced the risk of
schizophrenia; OR for those with IQ between 115 and 130 was
0.55 (95% CI 0.38 to 0.81), and those with IQ over 130 was 0.61
(95% CI 0.29 to 1.29).
Logistic regression of ﬁve studies assuming a common slope
showed a 3.7% increase in risk of schizophrenia with each one-point
decrease in IQ (95% CI 3.4% to 3.9%, pb0.0001). Examination of
whether a non-linear relationship between IQ score and schizophre-
nia provided a better ﬁt for the data was made by inclusion of a
quadratic term in the logistic regressionmodel. Quadratic effects were
signiﬁcantly heterogeneous between studies (p=0.002). Although
the overall quadratic effect was not signiﬁcant, study-speciﬁc
quadratic effects for two studies were signiﬁcantly positive, indicating
a weaker relationship between IQ and schizophrenia at higher
IQs (quadratic coefﬁcient 0.001, pb0.001) (Gunnell et al., 2002);
(quadratic coefﬁcient 0.0001, p=0.04) (Reichenberg et al., 2005);
while one study suggested a possibly stronger relationship between
IQ and schizophrenia at higher IQs (quadratic coefﬁcient −0.0002,
p=0.06) (Tiihonen et al., 2005).
3.4. Age of onset of schizophrenia
Both full-scale IQ and age of illness onset were available from
8 studies (Jones et al., 1994; Gunnell et al., 2002; Walker et al., 2002;
Caspi et al., 2003; Zammit et al., 2004; Reichenberg et al., 2005;
Osler et al., 2007; Urfer-Parnas et al., 2010). Meta-regression showed
strong evidence for greater case–control difference in samples with an
earlier mean age of onset (slope=0.03, SE 0.004, z=5.92, pb0.0001;
see Fig. 3).. Note: Random effect meta-analysis. Size of the squares is proportional to the weight of
ting, as ‘early’—7 to 12 years and ‘late’—16 to 19 years. The vertical line on x-axis at 0.00
rols.
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Fig. 2. Odds ratio for risk of schizophrenia across six IQ categories. Note: Estimated mean IQ refers to mean IQ of each category calculated according to proportion of people in the
category. IQ category 0–1SD is used as reference.
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To assess change in IQ during the premorbid period we looked at
both within and between study changes in IQ over time. Repeated
measures of IQ within the same individuals were available from three
cohorts totalling 86 cases. IQ was tested at age 8, 11 and 15 years in
the 1946 British birth cohort (Jones et al., 1994); at 5, 7, 11, and 13 in
the Dunedin birth cohort (Cannon et al., 2002); and at 8, 11 and 16 in
the 1958 British birth cohort (Crow et al., 1995). SMD in full-scale
IQ was plotted at these time points, however, there was no evidence
of signiﬁcant change in IQ over time.
IQ was measured earlier in the prospective birth cohort studies
(between age 7 and 12) than the conscript cohorts (between 16 and
19 years).We carried out separate meta-analysis dividing the samples
into two groups according to age of IQ testing (early versus late).
There was no signiﬁcant difference in premorbid IQ deﬁcit between
two groups (z=1.31, p=0.10). Meta-regression of SMD in full-scale
IQ on age at the time of IQ testing (years) found no evidence for
a greater IQ deﬁcit with advancing age (slope=0.007, SE 0.006,
z=1.13, p=0.26).
3.6. Gender effects on premorbid IQ
The review by Aylward et al. reported a higher deﬁcit in premorbid
IQ among male cases of schizophrenia (Aylward et al., 1984). WeFig. 3. Meta-regression of age of onset of schizophrenia on standardized mean
difference in premorbid full-scale IQ. Note: Each circle represents a study. Circle size
is proportional to study weight.carried out a meta-regression of SMD in full-scale IQ on proportion of
men in cases based on 12 samples, adjusting for the age of IQ testing
(Jones et al., 1994; Crow et al., 1995; Cannon et al., 2000; Gunnell
et al., 2002; Walker et al., 2002; Caspi et al., 2003; Zammit et al.,
2004; Reichenberg et al., 2005; Seidman et al., 2006; Osler et al., 2007;
Urfer-Parnas et al., 2010). We found no evidence of signiﬁcant
difference in premorbid IQ between studieswith different proportions
of men (slope=0.0016, SE 0.0025, p=0.55). There was also no
evidence of association between mean age of onset of a sample and
the male:female ratio.
3.7. Evaluation of publication bias
Inspection of a funnel plot and formal assessment using Egger's
test found no signiﬁcant indication of publication bias among reports
of full-scale IQ (Egger's intercept 0.98, p=0.08), verbal IQ (p=0.84)
or performance IQ (p=0.06).
4. Discussion
The neurodevelopmental hypothesis of schizophrenia argues that
aberrant brain development is detectable in subtle cognitive, motor
and other impairments present early in life, and that these differences
are markers of the neural process that predisposes or leads to
psychotic symptoms following further normal and/or abnormal
developmental events (Murray and Lewis, 1987; Weinberger, 1987).
The present meta-analysis of robust population-based datasets,
involving 4396 cases and 745720 controls conﬁrmed the presence
of an IQ deﬁcit of around 0.4 standard deviations among young
people who will later develop schizophrenia. This is a large effect
at the population level. Moreover, we observed a linear association
between schizophrenia and IQ, equating to a 3.7% increase in risk for
every 1-point decrease in premorbid IQ. These ﬁndings cannot be
explained only by a severely impaired subgroup, and are consistentwith
previous reports of a left-shift of the entire distribution of premorbid
IQ score in schizophrenia (Jones et al., 1994; David et al., 1997).
Unlike many putative risk factors for schizophrenia, this meta-
analysis showed strikingly consistent associations between premorbid
IQ and schizophrenia (Fig. 1). Nonetheless, some heterogeneity in effect
size was present. Possible sources of heterogeneity include differences
in measures of IQ and testing procedures, sample types (cohort versus
conscript studies), and length of follow up. For example, studies that
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et al., 2002; Osler et al., 2007) than studies that used individual
assessment, such as WISC, at a similar age (Cannon et al., 2000, 2002).
Nonetheless, the remarkably similar effect size obtained from aggrega-
tion of verbal and nonverbal IQ measures suggests that differences in
testing method may be relatively unimportant.
Greater premorbid IQ deﬁcits were strongly associated with an
earlier average age of illness onset (Fig. 3). We acknowledge that
mean age of onset in longitudinal studies can be inﬂuenced by length
of follow up. However, our ﬁnding is consistent with previous case
control studies (Pollack, 1960; Offord and Cross, 1971), and the only
previous review that examined this association (Aylward et al., 1984).
One conscript study reported only a modest deﬁcit in premorbid IQ
in cases of early onset schizophrenia (Gunnell et al., 2002), which
can be explained by its relatively short duration of follow. Moreover,
most military conscript cohorts excluded individuals presenting with
mental illness, mental retardation, epilepsy or any severe disability at
the time of draft assessment (Gunnell et al., 2002; Zammit et al., 2004;
Reichenberg et al., 2005;Urfer-Parnas et al., 2010). Thismayhave biased
the samples away from the early onset cases of schizophrenia, which
may be the most cognitively impaired, and hence underestimated
the association between low IQ and schizophrenia. Nonetheless, we
found two approximately linear relationships, between premorbid IQ
and risk for schizophrenia, and between premorbid IQ and age of onset
of schizophrenia.
These ﬁndings point toward a widespread neurodevelopmental
contribution to schizophrenia that operates across the entire range
of intellectual ability. This is in contrast to previous suggestions that
neurodevelopmental abnormalities may be conﬁned to (Murray et al.,
1992), or more prominent (Dean et al., 2003), in a subgroup of
schizophrenia cases characterized by poor premorbid intelligence,
early illness onset and male predominance. This is not to suggest that
other factors, alone or in combinations, are not important causes of
schizophrenia; and that discrete combination of genetic and environ-
mental factors may be involved. However, the data are consistent
with a continuity of developmental risk rather than a sub-type. The
majority of causal constellations are either manifest as, or mediated
by a cognitive or IQ-related factor. Such an effect may involve either
risk or protection, as discussed, below.
IQ in military conscripts was tested later (16–19 years) than in
birth cohorts (6–12 years). To eliminate the possibility of reverse
causality (i.e. low IQ as a result of early disease process or prodromal
state) three conscript studies excluded those who developed
psychosis within one (Reichenberg et al., 2005; Urfer-Parnas et al.,
2010), or two (Caspi et al., 2003) years after cognitive assessment.
However, the possibility of some prodromal cases in the remaining
two conscript studies cannot be ruled out (Gunnell et al., 2002;
Zammit et al., 2004). The mean effect size in conscript studies appears
to be slightly larger than that of birth cohorts (−0.46 versus−0.39),
although this difference was not statistically signiﬁcant. As the mean
effect size of IQ deﬁcit in ﬁrst-episode schizophrenia is−0.89 (Rajji et
al., 2009), one could argue that our ﬁndings suggest a subtle but
gradual deterioration of intellectual function over the premorbid
period. Progressive deterioration in premorbid IQ is in keeping with
both early static and dynamic brain lesion according to the neurode-
velopmental hypothesis of schizophrenia. A static lesion can interact
with other environmental factors (as well as normal maturational
processes) to result in deterioration in intellectual performance
during disease prodrome. Alternatively in a ‘dynamic model’
developmental mechanisms such as apoptosis and neuronal pruning
can give rise to cognitive deterioration much earlier in the premorbid
period (Woods, 1998). However, this hypothesis can be tested
conclusively only by repeated assessment within the same individ-
uals. Such longitudinal data were available from only three cohorts
(totalling 86 cases), so further studies with larger samples
are required. Our own view tends toward a more dynamic modelinvolving a developmental view of neural connectivity (Ridler et al.,
2006) that is discussed, below.
Additional possible sources of heterogeneity between studies
include differences in case deﬁnition and ascertainment, and gender
distribution between samples. Studies that used a narrower deﬁnition
of schizophrenia, or ascertained cases through hospitalization,
may detect a subset of more severe cases, resulting in larger effect
size (Crow et al., 1995; Seidman et al., 2006). Conversely, the use
of a broader diagnostic outcome (ICD 10 code F20–29) may have
diluted the effect size in one study (Walker et al., 2002). Despite sex
differences in cognitive development (Belenky et al., 1986) and age of
risk for schizophrenia (Kirkbride et al., 2006), we found no signiﬁcant
association between gender ratio and effect size. However, these
meta-regression analyses lacked power due to limited data-sets. In
contrast to a previous review (Aylward et al., 1984), we found no
difference in the magnitude of verbal versus nonverbal cognitive
decrements, although estimates of verbal IQ showed less heteroge-
neity between samples than those of nonverbal IQ, perhaps due to
differences in the range of tests used to estimate these scores.
A limitation of this review is lack of individual participant data,
which did not allow us to account for confounding factors in the
meta-analysis and meta-regression analyses (Thompson and Higgins,
2005). However, all individual studies adjusted their results for
several confounding factors (Table 1), and all reported an effect in the
same direction (Fig. 1).
An alternative explanatory model is that IQ is a protective factor,
buffering the impact of separate processes that, themselves, modify
(increase) the risk for psychosis. Such an interactive model draws
upon theories of cognitive reserve, a concept proposed to account
for apparent disparity between the degree of brain pathology and
its clinical manifestations (Stern, 2002). For example, up to 25% of
elderly people who perform normally in neuropsychological tests
prior to death meet criteria for Alzheimer's disease in post-mortem
histopathological examinations (Ince, 2001), suggesting that this
degree of pathology does not invariably result in clinical dementia. In
neuropsychiatric disorders such as schizophrenia cognitive reserve
may be associated with the risk of developing illness, as well as
symptom manifestation and long term functional outcome (Barnett
et al., 2006). While the passive model of cognitive reserve concerns
individual differences in brain structure (e.g. brain volume or neuron
density), the active model considers differences in the functionality
of brain processing. Active cognitive reserve can be measured by
performance in intelligence tests, educational and occupational
attainment, etc.We found that risk of schizophreniawas not restricted
to the lower end of the intelligence spectrum. Rather, we observed
strong evidence for a linear association, whereby those with average
IQ were at signiﬁcantly increased risk of developing schizophrenia
than those with higher IQ (Fig. 2). This suggests cognitive reserve may
be an active process in schizophrenia, and its protective effects may
operate throughout the range of intelligence spectrum.
Our results certainly support the view that schizophrenia includes
an element of abnormal neurodevelopment with phenotypic expres-
sion starting very early in life (Murray and Lewis, 1987; Weinberger,
1987; Jones et al., 1994). The existence of two approximately linear
relationships, where lower premorbid IQ is associated with both
increased risk and earlier onset of schizophrenia, suggests a gradient
of neurodevelopmental impairment where the relationship between
position on the distribution of cognitive ability and frequency of
schizophrenia is similar to that between, e.g., blood pressure and
stroke (Jones et al., 1994). These ﬁndings ﬁt the model of psychosis
as a continuum (van Os et al., 2009), where the association between
IQ and psychotic-like experiences extends beyond schizophrenia. The
same spectrum of neurodevelopmental impairment that is seen
in schizophrenia may also underlie results from general population
studies, where childhood IQ is also associated with risk for adult
(Kremen et al., 1998) and childhood (Horwood et al., 2008) non-
226 G.M. Khandaker et al. / Schizophrenia Research 132 (2011) 220–227clinical psychotic symptoms. Neuroimaging studies based on a Finnish
birth cohort showed that developmental failure to establish anatom-
ical connectivity in premotor cortex, and abnormal integration of
fronto-cerebellar-thalamic circuits may underlie both delayed infant
motor development and adult cognitive dysfunction in schizophrenia
(Ridler et al., 2006), suggesting that lower IQ in this context, before
and after the onset of disorder, is a marker of abnormal connectivity
implicated in the disorder. Thus, lower premorbid IQ might reﬂect
the underlying neurodevelopmental abnormality, which in some
individuals leads to the development of psychotic symptoms, alone
or in combination of other genetic and environmental factors.
On the whole, the studies reviewed here represent a major
advance in methodology of studies of schizophrenia epidemiology.
However, future studies on this topic should also include repeat
measures of IQ on same individuals using adequate samples; address
the question as to whether the deﬁcit is a general one involving
the concept of ‘G’ or whether speciﬁc sub-function(s) of cognition
are uniquely involved. Furthermore, the determinants of the IQ
distribution and normal neurodevelopment may conceal important
aspects of the genesis of later neuropsychiatric disorders such as
schizophrenia. The triangulation of cognitive epidemiological data
with neuroimaging and other neuroscience disciplines would help to
elucidate underlying such pathological processes.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.schres.2011.06.017.
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